LASERSIGHT INC /DE
8-K, 1998-01-02
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: STATE STREET RESEARCH PORTFOLIOS INC, N-30D, 1998-01-02
Next: STRONG SHORT TERM MUNICIPAL BOND FUND INC, 497J, 1998-01-02




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


Date of Report (date of earliest event reported):  January 2, 1998
                                                   (December 31, 1997)


                             LASERSIGHT INCORPORATED
                             -----------------------
              Exact name of registrant as specified in its charter


                                    Delaware
                                    --------
                  State or other jurisdiction of incorporation



       0-19671                                                    65-0273162
       -------                                                    ----------
Commission File Number                                         I.R.S. Employer
                                                              Identification No.


                 12161 Lackland Road, St. Louis, Missouri 63146
                 ----------------------------------------------
                     Address of Principal Executive Offices


Registrant's telephone number, including area code:  (314) 469-3220




<PAGE>



Item 5.   Other Events.

The press release issued by LaserSight  Incorporated  dated December 31, 1997 is
incorporated  by  reference  herein.   Additional   information  regarding  this
transaction  will be included in an additional  Current Report on Form 8-K to be
filed on or before January 14, 1998.

Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

      (c) Exhibits

      Exhibit 99. Press Release dated December 31, 1997



                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                                LaserSight Incorporated



Date:  January 2, 1998                          By:  /s/ Michael R. Farris
                                                    ------------------------
                                                     Michael R. Farris
                                                     Chief Executive Officer



                                   EXHIBIT 99

                               NASDAQ SYMBOL: LASE


LASERSIGHT INCORPORATED FOCUSES ON TECHNOLOGY;
SELLS TWO HEALTH SERVICES SUBSIDIARIES

ST. LOUIS, MO (Dec. 31, 1997) -- LaserSight Incorporated (NASDAQ: LASE) has sold
two subsidiaries -- MEC Health Care, Inc. and LSI Acquisition, Inc. -- to Vision
Twenty-One,  Inc. (NASDAQ:  EYES) for approximately $13 million,  including $6.5
million  paid in cash at closing and  approximately  $6.5 million paid in common
stock of Vision Twenty-One.

MEC Health Care,  Inc.  administers  HMO and  self-insured  vision plans. It was
acquired by  LaserSight  in October 1995.  LSI  Acquisition,  Inc. is a practice
management  company that manages the  ophthalmic  business known as the Northern
New  Jersey  Eye  Institute.  It was  established  by  LaserSight  in July 1996.
LaserSight's  estimated  after-tax  gain of $1.5 million to $2 million from this
transaction is subject to post-closing adjustments.

This transaction  improves  LaserSight's current liquidity and allows management
to focus the company's resources on its leading platform for refractive surgery.

Michael R. Farris, LaserSight's president and chief executive officer, says that
LaserSight was founded on state-of-the-art technology, and that it's always been
one of the company's  cornerstones.  He adds that several 1997 achievements make
this  technology  focus a natural step:  the  expansion of the company's  patent
portfolio;  final  development  and clinical  validation  of the  company's  LSX
refractive  laser system;  and the  acquisition and development of the automated
disposable keratome (AoDoK).

"These  achievements,  coupled  with the  emergence  of the  refractive  surgery
industry  around  LASIK,  confirm that our  strategic  position is on target for
1998," he adds.

A total of $3.5  million  from the net  proceeds  is being  repaid  to  Foothill
Capital  Corporation on the company's loans. In addition,  no financial covenant
compliance  will be required until the adjusted due date of the loans,  which is
June 15, 1998.

"We also are exploring options for the use of the balance of the proceeds,  such
as further  reduction  in debt,  enhancing  the  capital  base of the company or
redeeming a portion of the  company's  Series B Preferred  Stock,"  Farris says.
"And the company's  continuing to negotiate with potential  licensees  regarding
the patent  portfolio the company acquired from  International  Business Machine

<PAGE>

earlier  this  year."  LaserSight  Incorporated  is a  technology  company  that
provides  quality,  innovative  solutions  for  refractive,  medical  and  laser
applications,   in  addition  to   consulting   and   education   programs   for
ophthalmologists. The company sells its laser system in more than 30 countries.

Vision  Twenty-One  is an eye care practice  management  company that provides a
wide  range  of  services   to  its   integrated   networks   of   optometrists,
ophthalmologists, ambulatory surgical centers and retail optical centers.

This press release contains  forward-looking  statements regarding future events
and future  performance  of the company,  which involve risks and  uncertainties
that could materially affect actual results. Investors should refer to documents
that the  company  files from  time-to-time  with the  Securities  and  Exchange
Commission for a description of certain  factors that could cause actual results
to vary from current  expectations and the forward-looking  statements contained
in this press release. Such filings include,  without limitation,  the company's
Form 10-K, Form 10-Q and Form 8-K reports.

                                      # # #
For additional information please contact: Julie Tockman, APR
                                           Director, Corporate Relations
                                           LaserSight Incorporated
                                           (314) 469-3220 Ext. 3060
                                           Visit us on the Internet at www.lase.
                                           com


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission